メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
地域医療総合支援学講座
富山大学
附属病院
概要
フィンガープリント
ネットワーク
プロファイル
(2)
プロジェクト
(1)
研究成果
(39)
フィンガープリント
地域医療総合支援学講座が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Hepatocellular Carcinoma
94%
Liver
54%
Liver Disease
41%
Basic Fibroblast Growth Factor (bFGF)
37%
Advanced Hepatocellular Carcinoma
35%
Sorafenib
33%
Tumor
30%
Chemotherapy
29%
Chronic Hepatitis C
28%
5-fluorouracil (5-FU)
28%
Hepatocyte Growth Factor
28%
Liver Injury
28%
Overexpression
26%
Advanced Cirrhosis
23%
Japan
21%
Hepatitis C Virus
21%
Cisplatin
20%
Interleukin-8
18%
Primary Biliary Cirrhosis
18%
Wi-Fi
18%
Mouse Model
18%
Nonalcoholic Steatohepatitis
18%
Fas-mediated Apoptosis
18%
Percutaneous Radiofrequency Ablation
18%
Growth-related Genes
18%
Human Hepatoma Cells
18%
Mouse Liver
18%
Multidrug Resistance Protein 1 (MDR1)
18%
Intercellular Adhesion molecule-1 (ICAM-1)
18%
Docetaxel
18%
Direct-acting Antivirals
18%
Proton Pump Inhibitors
17%
Hepatitis B Virus Infection
16%
Hepatoma Cells
15%
Liver Fibrosis
15%
Lipopolysaccharide
15%
Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA)
14%
Dendritic Cells
13%
Hepatic Arterial Infusion Chemotherapy
13%
Fulminant Hepatitis
13%
Repair Method
13%
T Cells
13%
Median Progression-free Survival
13%
Survival Benefit
12%
Pathological Diagnosis
12%
Lymphoma Cells
12%
Differential Diagnosis
12%
Gemcitabine
12%
Hepatocellular Carcinoma Cells
12%
Hyperbilirubinemia
11%
T Cell Receptor
11%
Fulminant Hepatic Failure
11%
Median Overall Survival
11%
Human Liver
11%
Chronic Hepatitis B
11%
Human Hepatocellular Carcinoma
11%
Expression Pattern
11%
Electroporation
11%
Invasiveness
11%
Monoclonal Antibody
10%
Malignant Lymphoma
10%
Ultrasound
10%
Clinical Trials
10%
Cirrhosis
10%
Tumor Cells
10%
Irinotecan
10%
Liver Tumor
10%
Drug Resistance
10%
Helicobacter Pylori (H. pylori)
10%
Small Hepatocellular Carcinoma
10%
Interferon-α (IFN-α)
10%
Alanine Aminotransferase Level
10%
Type I Collagen
10%
Hepatocyte Apoptosis
10%
Point mutation
10%
Factor Level
10%
Cholangiocellular Carcinoma
10%
Acute Liver Injury
10%
Interleukin-1β
10%
Severe Liver Injury
10%
Liver Function
9%
Old Japanese
9%
Angiogenic Activity
9%
Human Hepatocellular Carcinoma Cell Line
9%
Covert Hepatic Encephalopathy
9%
Hepatic Angiomyolipoma
9%
Serum Interleukins
9%
Artificial Pleural Effusion
9%
Diaphragmatic Hernia
9%
Neutralizing Capacity
9%
Transaminitis
9%
Patients with Liver Disease
9%
Hepatologist
9%
Daclatasvir
9%
Asunaprevir
9%
Serum microRNA
9%
MicroRNA Profile
9%
Drug Resistance Gene
9%
Angiogenic Imbalance
9%
Isodisomy
9%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Neoplasm
47%
Liver Disease
38%
Liver Cirrhosis
34%
Chemotherapy
33%
Lymphocyte
29%
Radiofrequency Ablation
28%
Liver Injury
25%
Liver Tumor
22%
Chronic Hepatitis C
21%
Nonalcoholic Fatty Liver
20%
Overall Survival
20%
Messenger RNA
19%
Neutrophil
18%
Primary Biliary Cirrhosis
18%
Hepatocellular Carcinoma Cell Line
18%
Hepatoma Cell
18%
Multidrug Resistance
18%
Liver Graft
18%
Programmed Cell Death
18%
Arm
18%
Liver Fibrosis
18%
In Vitro
17%
Hepatic Encephalopathy
16%
Pancreas Cancer
16%
Disease
15%
Recurrent Disease
15%
Sorafenib
14%
Cell Line
14%
Gemcitabine
14%
Tumor Necrosis Factor
14%
Dendritic Cell
13%
T Cell
13%
Ascites
13%
Hepatocyte
13%
Cisplatin
13%
Differential Diagnosis
12%
Endoscopic Ultrasound Guided Fine Needle Biopsy
12%
Hepatitis B Virus
12%
Hyperbilirubinemia
11%
Antivirus Agent
11%
Signal Transduction
11%
Hepatitis B
11%
T Lymphocyte Receptor
11%
Fulminant Hepatic Failure
11%
Retrospective Study
11%
Lipopolysaccharide
11%
Chronic Hepatitis B
11%
Hepatic Arterial Infusion
10%
Abdominal Cancer
10%
Sepsis
10%
Liver Transplantation
10%
Lymphoma
10%
Progression Free Survival
10%
Collagen Type 1
10%
Butyric Acid
10%
Reverse Transcription Polymerase Chain Reaction
9%
Gut Microbiota
9%
Docetaxel
9%
Multiple Myeloma
9%
Fluoropyrimidine
9%
Interleukin 8
9%
Interferon
9%
Diaphragm Hernia
9%
Angiomyolipoma
9%
Daclatasvir
9%
Asunaprevir
9%
Irinotecan
9%
Human Umbilical Vein Endothelial Cell
9%
Focal Nodular Hyperplasia
9%
Interleukin-1
9%
Hepatoblastoma Cell Line
9%
Triploidy
9%
Liver Metastasis
9%
Protein P53
9%
Magnetic Resonance Imaging
9%
Low Drug Dose
9%
Mitomycin
9%
Rituximab
9%
Acinic Cell Carcinoma
9%
Dendritic Cell Function
9%
Macrophage
9%
Combined Therapy
9%
Placenta
9%
Pregnancy
9%
Endoscopic Ultrasound
9%
Fine-Needle Aspiration
9%
Citrullinemia Type II
9%
Adefovir Dipivoxil
9%
Subcorneal Pustular Dermatosis
9%
Ras Signaling
9%
Granulocyte Macrophage Colony Stimulating Factor
9%
Pre-Eclampsia
9%
Multidrug Resistance Protein 1
9%
Membrane Antigen
9%
Multidrug Resistance Associated Protein 2
9%
Elevated Transaminases
9%
Uniparental Disomy
9%
Nevus
9%
Ulcerative Colitis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
95%
Liver Cirrhosis
35%
Sorafenib
34%
Overall Survival
30%
Chemotherapy
30%
Scatter Factor
28%
Liver Disease
27%
Liver Injury
25%
Nonalcoholic Fatty Liver
20%
Disease
20%
Bile Duct Carcinoma
19%
Liver Fibrosis
18%
Fibroblast Growth Factor 2
18%
Fluorouracil
18%
Docetaxel
18%
Cisplatin
18%
Antivirus Agent
17%
Progression Free Survival
17%
Hepatic Encephalopathy
15%
Hepatitis C Virus
14%
Ascites
14%
Recurrent Disease
14%
Hepatitis B
12%
Irinotecan
12%
Monoclonal Antibody
12%
Cytotoxicity
12%
Alanine Aminotransferase
12%
Hyperbilirubinemia
11%
Chronic Hepatitis C
11%
Survival Time
11%
Intestine Flora
11%
Butyrate
11%
Combination Therapy
11%
Lipopolysaccharide
11%
Hepatitis B Virus
11%
Amino Acid
11%
Abdominal Cancer
10%
Clinical Trial
10%
Collagen Type 1
10%
Mitomycin
9%
Fluoropyrimidine
9%
Asunaprevir
9%
Daclatasvir
9%
Osteomalacia
9%
Adefovir Dipivoxil
9%
Interferon
9%
Hepatitis E
9%
Solid Malignant Neoplasm
9%
Multiple Myeloma
9%
Rat Model
9%
Esomeprazole
9%
Citrullinemia Type II
9%
Glucuronosyltransferase 1A1
9%
Subcorneal Pustular Dermatosis
9%
Sepsis
9%
microRNA
9%
Rhabdomyolysis
9%
Drug Resistance
9%
Urokinase
9%
Toxic Hepatitis
9%
Chronic Hepatitis B
9%
Intercellular Adhesion Molecule 1
9%
Carnitine
9%
Esophageal Squamous Cell Carcinoma
9%
Disease Exacerbation
9%
Autoimmune Hepatitis
9%
Hypertransaminasemia
9%
Nedaplatin
9%
Primary Biliary Cirrhosis
9%
Doxorubicin
9%
Lymphoma
9%
Small Cell Lung Cancer
9%
Granulocyte Macrophage Colony Stimulating Factor
9%
Infection
9%
Tolvaptan
9%
Gelatinase B
9%
Asthma
9%
Phosphatase
9%
Gene Delivery
9%
Colon Carcinoma
9%
Pancreas Cancer
9%
Adverse Event
8%
Acute Hepatitis
8%
Proton Pump Inhibitor
8%
Western Blot
8%
Malignant Neoplasm
7%
Tumor Necrosis Factor
7%
Messenger RNA
7%
Branched Chain Amino Acid
7%
Environmental Exposure
7%
Growth Factor
6%
Bilirubin
6%
Metabolic Disorder
6%
Gemcitabine
6%
Neoplasm
5%
Lactulose
5%
Liver Dysfunction
5%
Osteopontin
5%
Hedgehog
5%
Hydrogen Peroxide
5%